Clinical Trial Update: SGM-101 in Locally Advanced and Recurrent Rectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for SGM-101 in locally advanced and recurrent rectal cancer (Phase 2/Phase 3), status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• SGM-101

Snippet

Sponsor: Leiden University Medical Center | Conditions: Rectal Cancer, Recurrent Rectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN